(Q46141539)

19 December 2017

title

Coadministration of dabigatran etexilate and atorvastatin: assessment of potential impact on pharmacokinetics and pharmacodynamics (English)

1 reference

19 December 2017

1 reference

1 reference

1 reference

Joachim Stangier

1

1 reference

19 December 2017

Karin Rathgen

2

1 reference

19 December 2017

Hildegard Stähle

3

1 reference

19 December 2017

Kathrin Reseski

4

1 reference

19 December 2017

Thomas Körnicke

5

1 reference

19 December 2017

Willy Roth

6

1 reference

19 December 2017

publication date

1 January 2009

1 reference

19 December 2017

American journal of cardiovascular drugs

published in

1 reference

19 December 2017

volume

9

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

59-68

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/bf03256595

exact match

0 references

cites work

Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1007%2FBF03256595

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256595

Structure-based design of novel potent nonpeptide thrombin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256595

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256595

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256595

Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256595

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256595

Clinical Pharmacokinetics of Atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256595

Clinical pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor dabigatran etexilate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256595

Hepatic disease and drug pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256595

Drug-drug interaction with statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256595

Do statins have an antiarrhythmic activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256595

21 January 2018

Identifiers

DOI

10.1007/BF03256595

1 reference

19 December 2017

1 reference

19 December 2017